Celano Michael
Insider CIK 1377582 · KNSY Chief Financial Officer · OSUR Director, Director · LRMR Chief Financial Officer · REPH Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2026-01-26 | 2026-01-27 | 225,622 | — | $0 | 225,622 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award | 2026-01-26 | 2026-01-27 | 37,604 | — | $0 | 215,785 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2025-01-22 | 2025-01-24 | 205,111 | — | $0 | 205,111 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award | 2025-01-22 | 2025-01-24 | 34,185 | — | $0 | 178,181 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2024-01-17 | 2024-01-19 | 187,500 | — | $0 | 187,500 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award | 2024-01-17 | 2024-01-19 | 31,250 | — | $0 | 143,996 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2023-05-17 | 2023-05-18 | 5,000 | $3.73 | $18.6K | 112,746 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2023-01-31 | 2023-02-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award | 2023-01-31 | 2023-02-02 | 76,000 | — | $0 | 107,746 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | P Buy | 2022-09-16 | 2022-09-19 | 31,746 | $3.15 | $100.0K | 31,746 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | P Buy | 2022-08-12 | 2022-08-16 | 12,000 | $4.49 | $53.9K | 111,823 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2022-05-16 | 2022-05-18 | 24,762 | $5.25 | $130.0K | 99,823 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2022-05-16 | 2022-05-18 | 3,399 | $5.25 | $17.8K | 75,061 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2022-05-10 | 2022-05-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2022-01-18 | 2022-01-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2021-05-18 | 2021-05-19 | 13,559 | $9.59 | $130.0K | 78,460 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2021-05-17 | 2021-05-19 | 2,041 | $9.50 | $19.4K | 64,901 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2021-01-19 | 2021-01-21 | 42,000 | — | $0 | 42,000 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2020-09-29 | 2020-09-30 | 84,100 | — | $0 | 84,100 | SEC↗ |
| LRMR Larimar Therapeutics, Inc. | A Award deriv | 2020-05-28 | 2020-06-05 | 60,479 | — | $0 | 60,479 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2020-05-18 | 2020-05-19 | 8,143 | $15.97 | $130.0K | 66,942 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2020-05-15 | 2020-05-19 | 3,843 | $16.04 | $61.6K | 58,799 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2019-05-21 | 2019-05-22 | 15,330 | $8.48 | $130.0K | 62,642 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2019-01-18 | 2019-01-23 | 6,400 | — | $0 | 12,800 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2019-01-18 | 2019-01-23 | 60,592 | — | $0 | 60,592 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2019-01-18 | 2019-02-19 | 6,400 | — | $0 | 12,800 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2019-01-18 | 2019-02-19 | 67,500 | — | $0 | 67,500 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2019-01-18 | 2019-01-23 | 6,400 | — | $0 | 45,845 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-01-18 | 2019-01-23 | 12,672 | — | $0 | 39,445 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-01-18 | 2019-01-23 | 1,782 | $7.99 | $14.2K | 44,063 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-01-18 | 2019-02-19 | 1,782 | $7.99 | $14.2K | 45,855 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2019-01-18 | 2019-02-19 | 6,400 | — | $0 | 47,637 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2019-01-18 | 2019-02-19 | 14,464 | — | $0 | 41,237 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2019-01-02 | 2019-01-04 | 1,702 | $7.41 | $12.6K | 26,773 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2018-05-14 | 2018-05-15 | 1,578 | $15.98 | $25.2K | 47,312 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2018-05-08 | 2018-05-10 | 7,762 | — | $0 | 48,890 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award deriv | 2018-04-01 | 2018-04-03 | 40,000 | — | $0 | 40,000 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise deriv | 2018-01-18 | 2018-01-22 | 6,400 | — | $0 | 19,200 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2018-01-18 | 2018-01-22 | 6,400 | — | $0 | 30,495 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2018-01-18 | 2018-01-22 | 2,020 | $8.89 | $18.0K | 28,475 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2018-01-02 | 2018-01-04 | 40,000 | — | $0 | 40,000 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 24,095 | SEC↗ |
| REPH Recro Pharma, Inc. | M Exercise | 2017-09-28 | 2017-10-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| REPH Recro Pharma, Inc. | F Tax w/h | 2017-09-28 | 2017-10-02 | 1,905 | $9.04 | $17.2K | 4,095 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2017-05-16 | 2017-05-17 | 6,295 | — | $0 | 41,128 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2017-05-15 | 2017-05-17 | 3,284 | $15.13 | $49.7K | 34,833 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | S Sale | 2017-05-05 | 2017-05-09 | 44,962 | $14.95 | $672.2K | 38,117 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | M Exercise deriv | 2017-03-02 | 2017-03-06 | 15,000 | — | $0 | 0 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | S Sale | 2017-03-02 | 2017-03-06 | 15,000 | $12.00 | $180.0K | 83,079 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | M Exercise | 2017-03-02 | 2017-03-06 | 15,000 | $8.06 | $120.9K | 98,079 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | S Sale | 2017-02-09 | 2017-02-13 | 10,000 | $10.06 | $100.6K | 83,079 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | M Exercise deriv | 2017-01-31 | 2017-02-02 | 15,000 | — | $0 | 0 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | S Sale | 2017-01-31 | 2017-02-02 | 15,000 | $8.78 | $131.7K | 93,079 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | M Exercise | 2017-01-31 | 2017-02-02 | 15,000 | $8.28 | $124.2K | 108,079 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-01-18 | 2017-01-20 | 25,600 | — | $0 | 25,600 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2017-01-18 | 2017-01-20 | 35,800 | — | $0 | 35,800 | SEC↗ |
| REPH Recro Pharma, Inc. | A Award deriv | 2016-07-05 | 2016-07-05 | 140,000 | — | $0 | 140,000 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2016-05-17 | 2016-05-18 | 11,700 | — | $0 | 93,079 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2016-05-10 | 2016-05-12 | 4,177 | $6.84 | $28.6K | 81,379 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2015-05-12 | 2015-05-13 | 14,883 | — | $0 | 85,556 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2015-05-11 | 2015-05-13 | 3,645 | $5.53 | $20.2K | 70,673 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2014-05-22 | 2014-05-22 | 12,987 | — | $0 | 74,318 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2014-05-13 | 2014-05-15 | 4,913 | $6.52 | $32.0K | 61,331 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2013-05-15 | 2013-05-16 | 2,485 | $4.50 | $11.2K | 66,244 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2013-05-14 | 2013-05-16 | 17,505 | — | $0 | 68,729 | SEC↗ |
| KNSY KENSEY NASH CORP | D To issuer deriv | 2012-06-22 | 2012-06-26 | 20,200 | $12.86 | $259.8K | 0 | SEC↗ |
| KNSY KENSEY NASH CORP | D To issuer deriv | 2012-06-22 | 2012-06-26 | 30,000 | $21.50 | $645.0K | 0 | SEC↗ |
| KNSY KENSEY NASH CORP | D To issuer deriv | 2012-06-22 | 2012-06-26 | 4,400 | $10.02 | $44.1K | 0 | SEC↗ |
| KNSY KENSEY NASH CORP | D To issuer deriv | 2012-06-22 | 2012-06-26 | 12,000 | $9.52 | $114.2K | 0 | SEC↗ |
| KNSY KENSEY NASH CORP | D To issuer | 2012-06-22 | 2012-06-26 | 2,500 | $38.50 | $96.3K | 0 | SEC↗ |
| KNSY KENSEY NASH CORP | U Tender | 2012-06-19 | 2012-06-21 | 6,580 | $38.50 | $253.3K | 2,500 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | F Tax w/h | 2012-02-01 | 2012-02-03 | 4,210 | $11.30 | $47.6K | 42,370 | SEC↗ |
| OSUR ORASURE TECHNOLOGIES INC | A Award | 2012-02-01 | 2012-02-03 | 8,854 | — | $0 | 51,224 | SEC↗ |